Explore
Trendline
Ember LifeSciences Secures Strategic Investments to Enhance Cold Chain Technology
Ember LifeSciences Secures Strategic Investments to Enhance Cold Chain Technology
Read More
Trendline
Stord Secures $250 Million Investment, Doubling Valuation to $3 Billion
Stord Secures $250 Million Investment, Doubling Valuation to $3 Billion
Read More
Trendline
Gulf of America Logistics Appoints Jake Minner as VP of Operations Amid Expansion
Gulf of America Logistics Appoints Jake Minner as VP of Operations Amid Expansion
Read More
Trendline
Unilever Invests £150 Million in Port Sunlight to Enhance UK Supply Chain
Unilever Invests £150 Million in Port Sunlight to Enhance UK Supply Chain
Read More
Trendline
Maersk Settles with FMC Over Container Charges Dispute
Maersk Settles with FMC Over Container Charges Dispute
Read More
Trendline
Cool Carriers Appoints Mike Knowles as New Zealand Regional Representative
Cool Carriers Appoints Mike Knowles as New Zealand Regional Representative
Read More
Trendline
SCALA Event Highlights Role of Third-Party Logistics in Supply Chain Innovation
SCALA Event Highlights Role of Third-Party Logistics in Supply Chain Innovation
Read More
Trendline
Maersk Settles $1.9 Million with Federal Maritime Commission Over Container Charges
Maersk Settles $1.9 Million with Federal Maritime Commission Over Container Charges
Read More
Trendline
Cosm Medical Partners with Duke Health and Mayo Clinic for Personalized Pelvic Recovery Devices
Cosm Medical Partners with Duke Health and Mayo Clinic for Personalized Pelvic Recovery Devices
Read More
Trendline
MedTech Innovator Launches 2026 Accelerator Cohort and MTI Index for Medical Innovation
MedTech Innovator Launches 2026 Accelerator Cohort and MTI Index for Medical Innovation
Read More
Trendline
Bristol Myers Squibb to Engage in Goldman Sachs Global Healthcare Conference
Bristol Myers Squibb to Engage in Goldman Sachs Global Healthcare Conference
Read More
Trendline
Olympus Acquires BioProtect for $270 Million, Expands Prostate Cancer Treatment Portfolio
Olympus Acquires BioProtect for $270 Million, Expands Prostate Cancer Treatment Portfolio
Read More